Search Results - "Bouhlel, Linda"

Abstract 3230: The role of TRF2 on tumor progression in non-small cell lung cancer: potential modulating effect on myeloid cells by Bouhlel, Linda, Ilie, Marius, Signetti, Laurie, Cherfils-Vicini, Julien, Selva, Eric, Brest, Patrick, Marquette, Charles Hugo, Gilson, Eric, Hofman, Paul

“…Background: TRF2 is a key factor involved in telomere protection and has been found to be upregulated in various human cancers. The recent discovery by which…”
Get full text

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab by Bouhlel, Linda, Doyen, Jérôme, Chamorey, Emmanuel, Poudenx, Michel, Ilie, Marius, Gal, Jocelyn, Guigay, Joël, Benzaquen, Jonathan, Marquette, Charles-Hugo, Berthet, Jean-Philippe, Mouroux, Jérôme, Schiappa, Renaud, Padovani, Bernard, Hofman, Paul, Otto, Josiane

“…It has been found that occurrence of immune-related adverse events (irAEs) is associated with outcome in the treatment of advanced non-small-cell lung cancer…”
Get full text

The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases by Bouhlel, Linda, Hofman, Véronique, Maschi, Célia, Ilié, Marius, Allégra, Maryline, Marquette, Charles-Hugo, Audigier-Valette, Clarisse, Thariat, Juliette, Hofman, Paul

“…Introduction: Liquid biopsies (LB) are used routinely in clinical practice in two situations for late stage non-small-cell lung cancer (NSCLC) patients, (i) at…”
Get full text